BCCI Suspends Yusuf Pathan After He Fails Dope Test Allegedly Due To A Cough Syrup

Yusuf Pathan was given a five-month retrospective suspension for a doping violation after he “inadvertently ingested a prohibited substance, which can be commonly found in cough syrups,” the BCCI said in an official statement.


On 16 March 2017, while playing the Vijay Hazare Trophy for Baroda, Pathan had provided a urine sample that was later found to contain Terbutaline, a substance prohibited by the WADA (World Anti Doping Association).


The BCCI has back-dated the suspension from 15 August 2017, effectively meaning it will end on 14 January 2018.

On 27 October 2017, Pathan was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge. Mr Pathan responded to the charge by admitting the ADRV and asserting that it was caused by his ingestion of a medication containing Terbutaline that had been mistakenly given to him instead of the medication prescribed for him, which did not contain any prohibited substance.”

Yusuf pathan


The board stated that it was “satisfied” with Pathan’s explanation that he had taken the banned substance Terbutaline “inadvertently” while undergoing treatment for an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug.

Here is his official statement –

Here’s how Twitter reacted –

Pathan played 57 ODIs and 22 T20Is for India between 2008 and 2012 and was part of ICC World Twenty20 in 2007 and the 50-over World Cup in 2011.


Liked what you saw on DailySocial?

Follow us on FacebookTwitter and Instagram

Posted by

DailySocial Staff

Back to top